5-HT6 receptors: A novel target for cognitive enhancement

Pharmacology and Therapeutics

Volumn 108, Issue 3, 2005, Pages 320-333

  Mitchell, Ellen S ^a   Neumaier, John F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZENESULFONYL 5 METHOXY N,N DIMETHYLTRYPTAMINE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIDINYL]BENZENESULFONAMIDE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BGC 20 760; BGC 20 761; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUPERLAPINE; HALOPERIDOL; LY 586713; LYSERGIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; OLANZAPINE; RILAPINE; RO 4368554; SB 258510 A; SB 258585; SB 357134; SB 399885; SB 742457; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; TIOSPIRONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WAY 466; ZOTEPINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; SEROTONIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANXIETY DISORDER; BRAIN FUNCTION; COGNITION; DEMENTIA; DEPRESSION; DNA POLYMORPHISM; DRUG RECEPTOR BINDING; DRUG TARGETING; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; MEMORY DISORDER; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHIZOPHRENIA; ANIMAL; ANXIETY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; ANXIETY; COGNITION; DEPRESSION; HUMANS; MEMORY; MEMORY DISORDERS; NEUROTRANSMITTER AGENTS; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS;

EID: 28044437798     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.05.001     Document Type: Review

References (86)

1. M. Alvarez-Alvarez, G.L. Fernandez-Martinez, M. Gomez-Busto, F. Garcia-Centeno, V. Arias-Arias, and C. Sanchez-Salazar 5-Hydroxytryptamine 6 receptor (5-HT(6)) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country Neurosci Lett 339 2003 85 87
2. N. Barden Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression J Psychiatry Neurosci 29 2004 185 193
3. F.M. Benes, R.E. Burke, J. Walsh, S. Berretta, D. Matzilevich, and M. Minns Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus Mol Psychiatry 9 2004 932 945
4. J.C. Bentley, A. Bourson, F.G. Boess, K.C. Fone, C.A. Marsden, and N. Petit Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats Br J Pharmacol 126 1999 1537 1542
5. F.G. Boess, C. Riemer, M. Bos, J. Bentley, A. Bourson, and A.J. Sleight The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum Mol Pharmacol 54 1998 577 583
6. S.J. Bonasera 5-HT6 receptor agents modulate anxiety-related behaviors in the mouse AGS Annual Meeting, Chicago, IL 2001
7. M. Bos, A.J. Sleight, T. Godel, J.R. Martin, C. Riemer, and H. Stadler 5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides Eur J Med Chem 36 2001 165 178
8. 6 receptor in the rat brain: a study using antisense oligonucleotides J Pharmacol Exp Ther 274 1995 173 180
9. 6 receptors as emerging targets for drug discovery Annu Rev Pharmacol Toxicol 40 2000 319 334
10. S.M. Bromidge, A.M. Brown, S.E. Clarke, K. Dodgson, T. Gager, and H.L. Grassam 5-Chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2- benzothiophenesulfon-amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist J Med Chem 42 1999 202 205
11. 6 receptor antagonist SB 271046 in behavioral models of cognition Soc Neurosci Meet 776.19 2004
12. 6 receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat J Neural Transm 110 2003 577 590
13. L.A. Dawson, H.Q. Nguyen, and P. Li In vivo effects of the 5-HT6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate Br J Pharmacol 130 2000 23 26
14. L.A. Dawson, H.Q. Nguyen, and P. Li The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus Neuropsychopharmacology 25 2001 662 668
15. 6 receptor-selective upregulation of brain-derived neurotrophic factor mRNA in the rat brain FENS Abstr 2 2004 A126.5
16. C. Dubertret, N. Hanoun, J. Ades, M. Hamon, and P. Gorwood Family-based association study of the serotonin-6 receptor gene (C267T polymorphism) in schizophrenia Am J Med Genet 126B 2004 10 15
17. 6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585 Synapse 45 2002 191 199
18. S.Z. East, P.W. Burnet, R.W. Kerwin, and P.J. Harrison An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia Schizophr Res 57 2002 15 26
19. A.G. Foley, K.J. Murphy, W.D. Hirst, H.C. Gallagher, J.J. Hagan, and N. Upton The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats Neuropsychopharmacology 29 2004 93 100
20. K.C.F. Fone, C.A. Marsden, J.C. Bentley, and M.L. Woolley Abstract from 5th IUPHAR Meeting on Serotonin 2002 p77
21. 6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine Neuropharmacology 42 2002 170 180
22. 6 receptor mRNA levels in rat brain Schizophr Res 38 1999 7 12
23. 6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease Neuropsychopharmacology 29 2004 410 416
24. 6 receptor mRNA in the central nervous system of control or 5,7- dihydroxytryptamine-treated rats Synapse 23 1996 164 173
25. 6 receptor-like material in the rat central nervous system Brain Res 746 1997 207 219
26. R.A. Glennon, M. Lee, J.B. Rangisetty, M. Dukat, B.L. Roth, and J.E. Savage 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors J Med Chem 43 2000 1011 1018
27. 6 mRNA in the rat brain during ontogenetic development Naunyn-Schmiedeberg's Arch Pharmacol 357 1998 393 400
28. 6 receptors Neuropsychopharmacology 21 1999 68S 76S
29. 6 and 5-HT7 mRNA expression in rat brain Neuropsychopharmacology 21 1999 341 351
30. W.D. Hirst, B. Abrahamsen, F.E. Blaney, A.R. Calver, L. Aloj, and G.W. Price Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling Mol Pharmacol 64 2003 1295 1308
31. T6 receptor antagonist Soc Neurosci Meet 576.7 2003
32. A.S. Ivy, F.G. Rodriguez, C. Garcia, M.J. Chen, and A.A. Russo-Neustadt Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant Pharmacol Biochem Behav 75 2003 81 88
33. R. Kan, B. Wang, C. Zhang, Z. Yang, S. Ji, and Z. Lu Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese Neurosci Lett 372 2004 27 29
34. 6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation-an effect sensitive to NMDA receptor antagonism Neuropharmacology 47 2004 195 204
35. R. Kohen, M.A. Metcalf, N. Khan, T. Druck, K. Huebner, and J.E. Lachowicz Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor J Neurochem 66 1996 47 56
36. 6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop Mol Brain Res 90 2001 110 117
37. M. Kwon, F. Fischer, M. Matthisson, and P. Herrling List of drugs in development for neurodegenerative diseases Neurodegener Dis 1 2004 113 152
38. 6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex Synapse 51 2004 158 164
39. 6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders Schizophr Res 67 2004 63 70
40. M.D. Lindner, D.B. Hodges Jr., J.B. Hogan, A.F. Orie, J.A. Corsa, and D.M. Barten An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning J Pharmacol Exp Ther 307 2003 682 691
41. 6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia Schizophr Res 47 2001 49 58
42. H.Y. Meltzer, Z. Li, Y. Kaneda, and J. Ichikawa Serotonin receptors: their key role in drugs to treat schizophrenia Prog Neuro-Psychopharmacol Biol Psychiatry 27 2003 1159 1172
43. 6 receptors in memory formation Drug News Perspect 14 2001 396 400
44. 6 receptor gene polymorphism C267T with Parkinson's disease Neurology 58 2002 828 829
45. Y. Minabe, Y. Shirayama, K. Hashimoto, C. Routledge, J.J. Hagan, and C.R. Ashby Jr. Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study Synapse 52 2004 20 28
46. 6 receptor inhibition reverses scopolamine-induced memory deficit of object recognition in mature rats but not in young rats Soc Neurosci Meet 733.6 2004
47. F.J. Monsma, Y. Shen, R.P. Ward, M.W. Hamblin, and D.R. Sibley Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs Mol Pharmacol 43 1993 320 327
48. 6 receptor gene and schizophrenia Neurosci Lett 310 2001 17 20
49. 6 receptor variant produced by alternative splicing Mol Brain Res 64 1999 255 263
50. A. Orlacchi, T. Kawarai, E. Paciotti, A. Stefani, A. Orlacchio, and S. Sorbi Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease Neurosci Lett 325 2002 13 16
51. T. Otano, D. Frechilla, T. Cobreros, L.M. Cruz-Orive, T. Insausti, and R. Insausti Anxiogenic-like effects and reduced counting of immunolabelled antisense 5-HT6 receptors in rat nucleus accumbens by oligonucleotides Neuroscience 92 1999 1001 1009
52. J.G. Pelletier, and D. Pare Role of amygdala oscillations in the consolidation of emotional memories Biol Psychiatry 55 2004 559 562
53. M.T. Pena-Rangel, R. Mercado, and J. Hernandez-Rodriguez Regulation of glial Na+/K+-ATPase by serotonin: identification of participating receptors Neurochem Res 24 1999 643 649
54. E. Perry, M. Walker, J. Grace, and R. Perry Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 22 1999 273 280
55. J.L. Plassat, N. Amlaiky, and R. Hen Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase Mol Pharmacol 44 1993 229 236
56. B. Pouzet, M. Didriksen, and J. Arnt Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia Pharmacol Biochem Behav 71 2002 635 643
57. 6 antagonist MS-245 Pharmacol Biochem Behav 78 2004 263 268
58. 6 receptor Synapse 47 2003 218 224
59. 6 receptor antagonists SB-271046 and SB-399885 increase basal and learning induced NCAM-polysialylation in the rat dentate gyrus Soc Neurosci Meet 835.21 2003
60. 6 receptor antagonist J Med Chem 46 2003 1273 1276
61. 6 receptor antagonists enhance retention of a water maze task in the rat Psychopharmacology (Berl) 158 2001 114 119
62. B.L. Roth, S.C. Craigo, M.S. Choudhary, A. Uluer, F.J. Monsma Jr., and Y. Shen Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors J Pharmacol Exp Ther 268 1994 1403 1410
63. B.L. Roth, S.M. Hanizavareh, and A.E. Blum Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders Psychopharmacology 174 2004 17 24
64. C. Routledge, S.M. Bromidge, S.F. Moss, G.W. Price, W. Hirst, and H. Newman Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist Br J Pharmacol 130 2000 1606 1612
65. M. Ruat, E. Traiffort, J.M. Arrang, J. Tardivel-Lacombe, J. Diaz, and R. Leurs A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation Biochem Biophys Res Commun 193 1993 268 276
66. C. Sandi Stress, cognitive impairment and cell adhesion molecules Nat Rev Neurosci 5 2004 917 930
67. 6 receptor agonist Soc Neurosci Meet 394.11 2004
68. 6 receptor gene in schizophrenia Am J Med Genet 88 1999 120 122
69. A.J. Sleight, F.J. Monsma Jr., E. Borroni, R.H. Austin, and A. Bourson Effects of altered 5-HT6 expression in the rat: functional studies using antisense oligonucleotides Behav Brain Res 73 1996 245 248
70. 6 receptors Br J Pharmacol 124 1998 556 562
71. P. Svenningsson, E.T. Tzavara, F. Liu, A.A. Fienberg, G.G. Nomikos, and P. Greengard DARPP-32 mediates serotonergic neurotransmission in the forebrain Proc Natl Acad Sci U S A 99 2002 3188 3193
72. K.V. Szczepanski, J.A. Vivian, K. Dorsch, A. Blokland, L. Hedley, and C.K. Lieben Procognitive effects of the 5-HT6 receptor antagonist Ro 4368554 in rats Soc Neurosci Meet 290.20 2002
73. 6 receptor null mutant mice 4th IUPHRA Satellite Meeting on Serotonin, 81.2 1998
74. J. Thome, W. Retz, M. Baader, B. Pesold, M. Hu, and M. Cowen Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease J Neural Transm 108 2001 1175 1180
75. S.J. Tsai, H.J. Chiu, Y.C. Wang, and C.J. Hong Association study of serotonin-6 receptor variant (C267T) with schizophrenia and aggressive behavior Neurosci Lett 271 1999 135 137
76. 6 receptor polymorphism C267T in Alzheimer's disease Neurosci Lett 276 1999 138 139
77. 6] receptor gene in bipolar affective disorder and schizophrenia Am J Med Genet 96 2000 217 221
78. R.P. Ward, and D.M. Dorsa Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum J Comp Neurol 370 1996 405 414
79. P.L. Wood, D. Malthe-Sorenssen, D.L. Cheney, and E. Costa Increase of hippocampal acetylcholine turnover rate and the stretching-yawning syndrome elicited by alpha-MSH and ACTH Life Sci 22 1978 673 678
80. 6 receptors in retention of spatial learning in the Morris water maze Neuropharmacology 41 2001 210 219
81. 6 receptor antagonist, Ro 04-6790 Psychopharmacology 170 2003 358 367
82. 6 receptors Curr Drug Targets CNS Neurol Disord 3 2004 59 79
83. 6 receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders Neuropsychobiology 44 2001 172 175
84. 6 and 5-HT7 receptor gene expression in the rat hippocampus Mol Brain Res 45 1997 182 186
85. 6 receptor subtype in the rat brain Ann N Y Acad Sci 861 1998 244
86. 6) and upregulates 5-HT7 receptors in HeLa cells Neurosci Lett 288 2000 236 240